FEATURE Bristol Myers Squibb will acquire radiopharmaceutical therapeutics company RayzeBio for $62.50 a share in cash. RayZeBio close at $30.57 on Friday. In a press release, the companies said the total equity value of the deal is about $4.
Read full NASCAR article on Yahoo Sports
Read all NASCAR articles